Abdominal Radiology

, Volume 44, Issue 7, pp 2384–2391 | Cite as

Abdominal manifestations of hereditary hemorrhagic telangiectasia: a series of 333 patients over 15 years

  • Christopher L. WelleEmail author
  • Brian T. Welch
  • Waleed Brinjikji
  • Eric C. Ehman
  • Sudhakar K. Venkatesh
  • Matthew P. Johnson
  • Vivek N. Iyer
  • Michael D. Leise
  • Christopher P. Wood



Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant multi-organ vascular disorder that commonly affects the gastrointestinal tract and the liver resulting in telangiectasias and arteriovenous malformations (AVMs). Previous studies looking at the prevalence of liver and abdominal organ involvement in HHT have been limited by differing imaging techniques and sample size limitations. We sought to define the prevalence of HHT related abdominal vascular abnormalities using optimized multiphasic contrast-enhanced abdominal computed tomography (CT) exams in a large cohort of HHT patients.


Between January 2001 and May 2015; we identified a total of 333 consecutive HHT patients who had undergone a dedicated HHT protocol multiphase abdominal CT at our institution. The CT exams were reviewed by three board certified abdominal radiologists for the presence of vascular abnormalities involving the liver, pancreas, spleen, and other abdominal organs. Vascular abnormalities involving the liver were further categorized as telangiectasias, large confluent vascular masses, perfusion abnormalities, or hepatic shunts.


In patients with abdominal vascular abnormalities, the liver was the most commonly involved organ, with 180 out of 333 (54.1%) patients demonstrating at least one hepatic vascular abnormality (telangiectasia, confluent vascular mass, transient perfusion abnormalities, and hepatic shunts), with most (70.0%) demonstrating multiple hepatic vascular abnormalities. The other most common organs involved included the pancreas (18.0%), spleen (6.3%), and small bowel (4.5%).


In patients with the clinical diagnosis of HHT, greater than half demonstrate an abdominal vascular abnormality, with the most commonly involved organ being the liver. These may be under recognized on routine or single phase contrast-enhanced CT of the abdomen. This supports the use of optimized multiphasic abdominal CT exams as an important tool for the evaluation and screening of patients with HHT.


Hereditary hemorrhagic telangiectasia (HHT) Abdominal vascular abnormalities Telangiectasia Hepatic Vascular Shunts 


Compliance with ethical standards

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, Manabe M, Nozaki J, Inoue S, Koizumi A (2002) Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 19 (2):140-148. CrossRefGoogle Scholar
  2. 2.
    Kjeldsen AD, Vase P, Green A (2000) [Hereditary hemorrhagic telangiectasia. A population-based study on prevalence and mortality among Danish HHT patients]. Ugeskr Laeger 162 (25):3597-3601Google Scholar
  3. 3.
    Guttmacher AE, Marchuk DA, White RI, Jr. (1995) Hereditary hemorrhagic telangiectasia. N Engl J Med 333 (14):918-924. CrossRefGoogle Scholar
  4. 4.
    Peery WH (1987) Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 82 (5):989-997CrossRefGoogle Scholar
  5. 5.
    Brinjikji W, Nasr DM, Wood CP, Iyer VN (2017) Pulmonary Arteriovenous Malformations Are Associated with Silent Brain Infarcts in Hereditary Hemorrhagic Telangiectasia Patients. Cerebrovasc Dis 44 (3-4):179-185. CrossRefGoogle Scholar
  6. 6.
    Siddiki H, Doherty MG, Fletcher JG, Stanson AW, Vrtiska TJ, Hough DM, Fidler JL, McCollough CH, Swanson KL (2008) Abdominal findings in hereditary hemorrhagic telangiectasia: pictorial essay on 2D and 3D findings with isotropic multiphase CT. Radiographics 28 (1):171-184. CrossRefGoogle Scholar
  7. 7.
    Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91 (1):66-67CrossRefGoogle Scholar
  8. 8.
    McDonald J, Wooderchak-Donahue W, VanSant Webb C, Whitehead K, Stevenson DA, Bayrak-Toydemir P (2015) Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet 6:1. CrossRefGoogle Scholar
  9. 9.
    Garcia-Tsao G (2007) Liver involvement in hereditary hemorrhagic telangiectasia (HHT). J Hepatol 46 (3):499-507. CrossRefGoogle Scholar
  10. 10.
    Buscarini E, Gandolfi S, Alicante S, Londoni C, Manfredi G (2018) Liver involvement in hereditary hemorrhagic telangiectasia. Abdom Radiol (NY).
  11. 11.
    Ravard G, Soyer P, Boudiaf M, Terem C, Abitbol M, Yeh JF, Brouard R, Hamzi L, Rymer R (2004) Hepatic involvement in hereditary hemorrhagic telangiectasia: helical computed tomography features in 24 consecutive patients. J Comput Assist Tomogr 28 (4):488-495CrossRefGoogle Scholar
  12. 12.
    Memeo M, Stabile Ianora AA, Scardapane A, Buonamico P, Sabba C, Angelelli G (2004) Hepatic involvement in hereditary hemorrhagic telangiectasia: CT findings. Abdom Imaging 29 (2):211-220. CrossRefGoogle Scholar
  13. 13.
    Plauchu H, de Chadarevian JP, Bideau A, Robert JM (1989) Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32 (3):291-297. CrossRefGoogle Scholar
  14. 14.
    Reilly PJ, Nostrant TT (1984) Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol 79 (5):363-367Google Scholar
  15. 15.
    Barral M, Sirol M, Place V, Hamzi L, Borsik M, Gayat E, Boudiaf M, Soyer P (2012) Hepatic and pancreatic involvement in hereditary hemorrhagic telangiectasia: quantitative and qualitative evaluation with 64-section CT in asymptomatic adult patients. Eur Radiol 22 (1):161-170. CrossRefGoogle Scholar
  16. 16.
    Canzonieri C, Centenara L, Ornati F, Pagella F, Matti E, Alvisi C, Danesino C, Perego M, Olivieri C (2014) Endoscopic evaluation of gastrointestinal tract in patients with hereditary hemorrhagic telangiectasia and correlation with their genotypes. Genet Med 16 (1):3-10. CrossRefGoogle Scholar
  17. 17.
    Chamberlain SM, Patel J, Carter Balart J, Gossage JR, Jr., Sridhar S (2007) Evaluation of patients with hereditary hemorrhagic telangiectasia with video capsule endoscopy: a single-center prospective study. Endoscopy 39 (6):516-520. CrossRefGoogle Scholar
  18. 18.
    Greve E, Moussata D, Gaudin JL, Lapalus MG, Giraud S, Dupuis-Girod S, Calender A, Plauchu H, Saurin JC (2010) High diagnostic and clinical impact of small-bowel capsule endoscopy in patients with hereditary hemorrhagic telangiectasia with overt digestive bleeding and/or severe anemia. Gastrointest Endosc 71 (4):760-767. CrossRefGoogle Scholar
  19. 19.
    Ingrosso M, Sabba C, Pisani A, Principi M, Gallitelli M, Cirulli A, Francavilla A (2004) Evidence of small-bowel involvement in hereditary hemorrhagic telangiectasia: a capsule-endoscopic study. Endoscopy 36 (12):1074-1079. CrossRefGoogle Scholar
  20. 20.
    Longacre AV, Gross CP, Gallitelli M, Henderson KJ, White RI, Jr., Proctor DD (2003) Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 98 (1):59-65. CrossRefGoogle Scholar
  21. 21.
    Proctor DD, Henderson KJ, Dziura JD, Longacre AV, White RI, Jr. (2005) Enteroscopic evaluation of the gastrointestinal tract in symptomatic patients with hereditary hemorrhagic telangiectasia. J Clin Gastroenterol 39 (2):115-119Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Christopher L. Welle
    • 1
    Email author
  • Brian T. Welch
    • 1
  • Waleed Brinjikji
    • 1
  • Eric C. Ehman
    • 1
  • Sudhakar K. Venkatesh
    • 1
  • Matthew P. Johnson
    • 2
  • Vivek N. Iyer
    • 3
  • Michael D. Leise
    • 4
  • Christopher P. Wood
    • 1
  1. 1.Department of RadiologyMayo ClinicRochesterUSA
  2. 2.Department of Biomedical Statistics and InformaticsMayo ClinicRochesterUSA
  3. 3.Department of Pulmonary and Critical Care MedicineMayo ClinicRochesterUSA
  4. 4.Department of Gastroenterology and HepatologyMayo ClinicRochesterUSA

Personalised recommendations